Revised HAS-BLED score for bleeding prediction in atrial fibrillation patients with oral anticoagulants
Completed
- Conditions
- Can revised HAS-BLED score be used to predict bleeding events in AF patients with oral anticoagulants?Revised HAS-BLED, anticoagulation, atrial fibrillation, SAMe-TT2R2, bleeding
- Registration Number
- TCTR20200921001
- Lead Sponsor
- o
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 256
Inclusion Criteria
AF patients receiving oral anticoagulants including warfarin or NOACs.
Exclusion Criteria
1. Patients with contraindication of warfarin or duration of warfarin use below one year
2. Patients with prosthetic heart valve and/or mitral valve repair
3. Patients with thrombocytopenia (platelet count below 100,000/mm3), myeloproliferative disorders(essential thrombocythemia, chronic myeloid leukemia, polycythemia vera, agnogenic myeloid metaplasia) or hyperviscosity syndrome
4. Patients with warfarin discontinuation from surgery or intervention
5. Pregnancy
6. Patients participating in other concealed study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MB and/or CRNMB 1 year Proportion of bleeding events
- Secondary Outcome Measures
Name Time Method Total bleeding 1 year Proportion of bleeding events,Minor bleeding 1 year Proportion of bleeding events